featured
Plasma Cell–Directed Therapies in Monoclonal Gammopathy–Associated Scleromyxedema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Plasma Cell-Directed Therapies in Monoclonal Gammopathy-Associated Scleromyxedema
Blood 2020 Feb 06;[EPub Ahead of Print], T Mahévas, B Arnulf, JD Bouaziz, C Bulai Livideanu, A Osio, A Servy, B Cribier, B Sassolas, M Jachiet, L Michel, P Aucouturier, D Lipsker, C Frances, E Sbidian, M Rybojad, V Descamps, M D'Incan, P Humbert, M Beylot-Barry, T Passeron, C de Moreuil, RY Taha, O Hermine, A Dupuy, S Barbarot, S Debarbieux, O Carpentier, F Brault, JL Schmutz, D Thomas-Beaulieu, P Modiano, C Zarnitsky, F Lifermann, E Baubion, N Limal, F Le Bras, M Le Moigne, M Tauber, A Talbot, R Prud'homme, S Peltier, A de Masson, M Battistella, M Bagot, A Mékinian, O FainFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.